These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2876683

  • 1. Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.
    Farr M, Symmons DP, Blake DR, Bacon PA.
    Ann Rheum Dis; 1986 Sep; 45(9):761-4. PubMed ID: 2876683
    [Abstract] [Full Text] [Related]

  • 2. Leucopenia during sulphasalazine treatment for rheumatoid arthritis.
    Marabani M, Madhok R, Capell HA, Hunter JA.
    Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110
    [Abstract] [Full Text] [Related]

  • 3. Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy.
    Amos RS, Bax DE.
    Br J Rheumatol; 1988 Dec; 27(6):465-8. PubMed ID: 2904830
    [Abstract] [Full Text] [Related]

  • 4. Fatal agranulocytosis in sulfasalazine treated rheumatoid arthritis.
    Guillemin F, Aussedat R, Guerci A, Lederlin P, Trechot P, Pourel J.
    J Rheumatol; 1989 Aug; 16(8):1166-7. PubMed ID: 2573730
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine.
    Bliddal H, Helin P.
    Clin Rheumatol; 1987 Jun; 6(2):244-50. PubMed ID: 2887331
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyperleucocytosis following G-CSF treatment for sulfasalazine-induced agranulocytosis.
    Chan K, Farooq R.
    BMJ Case Rep; 2015 Jul 15; 2015():. PubMed ID: 26178004
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of drug-induced agranulocytosis with recombinant GM-CSF.
    Palmblad J, Jonson B, Kanerud L.
    J Intern Med; 1990 Nov 15; 228(5):537-9. PubMed ID: 1979344
    [Abstract] [Full Text] [Related]

  • 12. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
    Bliddal H, Eiberg B, Helin P, Svejgaard A.
    Ann Rheum Dis; 1989 Jul 15; 48(7):539-41. PubMed ID: 2570550
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Clinical features, and estimation of its incidence.
    Keisu M, Ekman E.
    Eur J Clin Pharmacol; 1992 Jul 15; 43(3):215-8. PubMed ID: 1358622
    [Abstract] [Full Text] [Related]

  • 15. Haematological side-effects of sulphasalazine in inflammatory arthritis.
    Hopkinson ND, Saiz Garcia F, Gumpel JM.
    Br J Rheumatol; 1989 Oct 15; 28(5):414-7. PubMed ID: 2571387
    [Abstract] [Full Text] [Related]

  • 16. Leucopenia, thrombocytopenia and lymphadenopathy associated with sulphasalazine.
    McKenna KE, Burrows D.
    Clin Exp Dermatol; 1994 Sep 15; 19(5):419-20. PubMed ID: 7955504
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.